News from Zyme and the companies we work with.
DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences
Brings decentralized, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market Paris, France, 16 June 2026: DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis [...]
EpilepsyGTx partners with ClearPoint Neuro to support targeted delivery of lead gene therapy in epilepsy
ClearPoint Neuro’s system enables precise delivery to the seizure focus, ensuring best possible efficacy and safety of EpilepsyGTx’s investigational gene therapy Partnership will support first-in-human Phase 1/2a clinical trials of [...]
DDW introduces new series of events aimed at connecting innovation with investment in early-stage drug discovery
Three-part event series will comprise a digital forum (30th September 2026), and two in-person events (London, UK, 4th November 2026, and Basel, Switzerland, March 2027) Focused on technology, innovation, and [...]
Camena Bioscience appoints Gregory P. McGuinness as CEO
Internationally recognised business executive with extensive operational experience in life sciences, diagnostics and pharma Appointment will lead strategic growth plans, including commercialisation of the gSynth® platform for AI-driven antibody discovery, [...]
Eppendorf Focuses Outreach Programmes to Advance STEM Education in Europe
Hamburg, DE, 07 JULY 2026 – Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today [...]
Bio-Rad Launches Vericheck ddPCR Kits Compatible with QX700 Platform for Biopharma Quality Control and Cell and Gene Therapy Workflows
New Vericheck ddPCR™ Kits Combine Highly Specific and Highly Sensitive DNA Detection and Quantification with the QX700™ System’s Seven-Color Multiplexing, Simplified Workflow, and Scalable Throughput HERCULES, Calif.—July 07, 2026—Bio-Rad Laboratories, [...]
Exonate appoints Olav Hellebø as Chief Executive Officer
Appointment of experienced executive forms part of the Company’s strategy to build momentum across its proprietary platform and therapeutic programs targeting retinal diseases Company is preparing a Phase IIb clinical [...]
Welbeck Health Partners Adopts OMED Health’s Home-Based SIBO Testing Pathway Across Its Network
Patients complete SIBO breath testing at home, with diagnosis provided by an in-house OMED Health GI doctor and results returned to Welbeck's clinicians via an online portal Home-based pathway widens [...]
Tecan accelerates Data-Driven Lab journey with Agentic AI developments powered by NVIDIA
Männedorf, Switzerland, June 24, 2026: Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics [...]
FairJourney Bio and AbTherx Partner to Offer Fully Integrated Antibody Discovery
FairJourney Bio brings AbTherx’s Atlas transgenic mouse technologies in-house, enabling partner programmes to run from immunisation to a developability-assessed lead in one continuous workflow Partnership announced at BIO International Convention [...]
TRIMTECH Therapeutics brings total seed round to $47M with additional investment of $14M to further develop TRIMTAC and TRIMGLUE targeted protein degradation portfolio
Johnson & Johnson’s corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc. (“JJDC”), and BGF join existing investors Cambridge Innovation Capital, DDF, M Ventures, Pfizer Ventures, Eli Lilly [...]
Pheno Therapeutics granted FDA IND clearance for lead multiple sclerosis therapeutic candidate PTD802
US FDA clearance enables first-in-human study of PTD802, a selective GPR17 antagonist Small molecule therapeutic designed to promote remyelination in neurological diseases such as multiple sclerosis Milestone supports Pheno Therapeutics’ [...]
